Calling all cyclists – Ride4Epilepsy

Whether you’re an elite cyclist, looking for a fun family sporting event or a beginner rider, VIVA! Communications is calling all cyclists ahead of the annual Ride4Epilepsy in September. Join Olympic medallist and six-time World Champion cyclist, Marion Clignet, Collingwood cheer-squad identity and father of a daughter with epilepsy, Joffa Corfe, and cycling enthusiasts and…

Read More

Identifying children living with Progeria

At VIVA! we’ve been busily researching Progeria, also known as the Hutchinson-Gilford Progeria Syndrome, and assisting our GLOBALHealthPR partners in a worldwide search for children diagnosed with the condition. Progeria is a rare and fatal genetic condition that causes rapid ageing in young children. Progeria symptoms include growth failure, loss of body fat and hair,…

Read More

Are we doing enough to ensure the health of Aussie men?

As International Men’s Health Week wraps up for the year, Team VIVA! takes a look at some of the ways Australians are raising awareness for men’s health and welfare issues, and how new research suggests more needs to be done to ensure the future health of Aussie men. International Men’s Health Week, an initiative of…

Read More

Newborns suffering from ultra-rare and fatal genetic disorder now have chance at life

Newborns with the ultra-rare and fatal genetic disorder – molybdenum cofactor deficiency (MoCD) Type A – now have a chance at life after Alexion Pharmaceuticals, Inc. purchased the assets and patents from Orphatec Pharmaceuticals GmbH, in order to accelerate the development of an investigational therapy to cure the fatal disorder.  MoCD Type A is characterised…

Read More